US Patent 9006400 Fibroblast growth factor-21-Fc fusion proteins
Patent 9006400 was granted and assigned to Novartis on April, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 30 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+301 characters)
Article
Patent abstract
The invention relates to the identification of fusion proteins comprising polypeptide and protein variants of fibroblast growth factor 21 (FGF21) with improved pharmaceutical properties. Also disclosed are methods for treating FGF21-associated disorders, including metabolic conditions.
Edits on 1 Nov, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09006400 Fibroblast growth factor-21-Fc fusion proteins US Patent 9006400 Fibroblast growth factor-21-Fc fusion proteins
Infobox
Patent Number
0900640000
Patent Number
900640000
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
090064000
Date of Patent
April 14, 2015
0Patent Application Number
136261940
Date Filed
September 25, 2012
0Official Website
Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
090064000
Date of Patent
April 14, 2015
0Patent Application Number
136261940
Date Filed
September 25, 2012
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 29 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09006400 Fibroblast growth factor-21-Fc fusion proteins
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09006400
Date of patent
April 14, 2015
Patent application number
13626194
Date Filed
September 25, 2012
Patent primary examiner
Find more entities like US Patent 9006400 Fibroblast growth factor-21-Fc fusion proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
